A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation by Mahiane, G. S. et al.
A General HIV Incidence Inference Scheme Based on
Likelihood of Individual Level Data and a Population
Renewal Equation
Guy Severin Mahiane1*, Rachid Ouifki1, Hilmarie Brand1, Wim Delva1,2, Alex Welte1
1 South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa, 2 International Centre for Reproductive Health,
Gent University, Gent, Belgium
Abstract
We derive a new method to estimate the age specific incidence of an infection with a differential mortality, using individual
level infection status data from successive surveys. The method consists of a) an SI-type model to express the incidence rate
in terms of the prevalence and its derivatives as well as the difference in mortality rate, and b) a maximum likelihood
approach to estimate the prevalence and its derivatives. Estimates can in principle be obtained for any chosen age and time,
and no particular assumptions are made about the epidemiological or demographic context. This is in contrast with earlier
methods for estimating incidence from prevalence data, which work with aggregated data, and the aggregated effect of
demographic and epidemiological rates over the time interval between prevalence surveys. Numerical simulation of HIV
epidemics, under the presumption of known excess mortality due to infection, shows improved control of bias and variance,
compared to previous methods. Our analysis motivates for a) effort to be applied to obtain accurate estimates of excess
mortality rates as a function of age and time among HIV infected individuals and b) use of individual level rather than
aggregated data in order to estimate HIV incidence rates at times between two prevalence surveys.
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Introduction
Accurate HIV incidence estimates are essential for determining
public health priorities and assessing the impact of interventions in
order to monitor the HIV epidemic, but because HIV infections
are silent events, estimation of HIV incidence is difficult [1]. The
most direct approach to estimating HIV incidence is through
observational studies, in which subjects are periodically monitored
for HIV infection, but such studies are time consuming and
expensive, and may provide biased estimates. Another approach
that has attracted considerable attention [2–6] is the use of HIV
tests that can discriminate recent infections, based on a single
specimen. The theoretical underpinnings of this approach have
recently been put on a sound footing under general assumptions
[7] but in practice the tests themselves, despite recent progress
[8,9] have not yet evolved to the point where they yield
consistently informative estimates [10–13]. Numerous ways have
also been proposed to relate incidence to (possibly multiple) cross-
sectional measures of prevalence [14–25]. Most of these use age-
specific prevalence from only one survey [14,16–18,22], others
rely on long time series [15,23,26].
Among the methods that use multiple unlinked cross-sectional
surveys, three methods warrant a closer look. They are variations
on the theme of interpreting two successive age structured
prevalence surveys into estimates of parameters of a population
dynamic model which aggregates the effects of infection and
mortality over the time between the two surveys. Brunet and
Struchiner [24] derived a fundamental formula, which also forms
the core of the present work, expressing the incidence as a function
of excess mortality rates and prevalence, in an age and time
structured susceptible-infected (SI) model. Their method of
estimating incidence is based on smoothing data from repeated
age structured prevalence surveys and estimates of cumulative
excess mortality rates. Hallett et al. [19] proposed a variation on
this theme, now commonly cited, and used to estimate HIV
incidence in sub-Saharan African settings [19,27,28], which is
based on the assumption of constant incidence within age bins,
and during the period between two surveys [19]. Brookmeyer and
Konikoff [29] proposed yet another variation, which parameterises
the different mortalities of the infected and susceptible population
into a survival ratio.
In this paper, we propose an alternative approach based on
serostatus observations over a range of times and ages, such as for
example multiple age-structured prevalence surveys. It entails
viewing infection, ageing, and death as continuous processes at
any point in time, and merely using available serostatus data to
obtain the best possible estimate of the rate of change of
prevalence at an age and time of interest, we circumvent the
need to calculate artefactual aggregated summary parameters.
Thus, the fundamental equation first used for this purpose by
Brunet and Struchiner [24] can be applied more systematically.
We use a simulated epidemic to assess applicability to the case of
HIV. The special case of a pure birth cohort is also invoked, to
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demonstrate subtleties of the assumptions and approximations,
and to facilitate comparison of methodological choices. The
performance of the introduced estimator is compared to those
proposed by Brunet and Struchiner [24], Hallet et al. [19] and
Brookmeyer and Konikoff [29].
Methods
General Framework
Consider, in an age structured population, a non remissible
infection which induces a difference in mortality rate. This can be
embodied in an SI-type model (See Text S1, Appendix A) with a
‘force of infection’ or incidence rate, i.e. as the number of infections per
susceptible person-time, l a,tð Þ. The idea that people of age a at time t
become the people of age azd after a period of duration d, to the
extent that they survive, is a core tenet of what is usually referred
to as ‘population renewal’. Making no assumptions about transmission
dynamics, and merely parameterising the process of ageing,
infection, and death, through rates, leads, as demonstrated by
Brunet and Struchiner [24,30], to
l(a,t)~
1
1{p(a,t)
L
Lt
p(a,t)z
L
La
p(a,t)
 
zD(a,t)p(a,t) ð1Þ
where p(a,t) and D(a,t) represent the prevalence and excess
mortality rate of the infected individuals respectively. In the SI
model, people aged a at time t move out of the susceptible
population at the total rate l a,tð Þzm a,tð Þ, where m(a,t) is the
background mortality rate. Individuals who become infected enter
the infected class, and people of the infected class move out of that
class at the rate m a,tð ÞzD a,tð Þ. In reality, individuals will have
particular infection times, and it is possible to consider further
discriminating the infected population by ‘time since infection’
(sometimes called ‘duration’) and to explicitly have mortality rates
depend on this additional parameter. The simplified model does
not disregard this fact, but requires that the excess mortality
parameter properly accounts for it. The point behind the
simplification is to map the model onto observable data, and time
since infection is not observable – if it were, we would have simple
ways of estimating recent incidence rate from the distribution of
times since infection.
The model equations treat all population counts, and hence
prevalence, as smooth functions of age and time. Initially, this is
conceived as a closed population, but in a more general setting,
where the population is subject to migration, D(a,t) can still be
defined, namely as the difference in net attrition rate between the
infected and uninfected individuals. This is discussed in Text S2
(Section IV).
Equation (1) shows that only the difference in mortality rate
between the infected and uninfected population is needed, to turn
knowledge of prevalence into knowledge about incidence. In
practice, estimates of the ‘excess’ mortality rate may be inextricably
linked to estimates of the background mortality rates, and the
nuances of how these estimates are to be obtained are beyond
the present work. Brunet and Struchiner [24] suggested using the
integral form of equation (1) to estimate a ‘locally averaged incidence’,
whereas we focus on the instantaneous incidence. In the
remainder of this paper, we develop a method for processing
prevalence data, and do not explore in any detail the methods for
estimating the excess mortality rates, D(a,t).
Formula (1) implies that partial derivatives of the prevalence, with
respect to age and time, are required to calculate the incidence
rate. In practice, only individual HIV serostatus observations are
recorded. One way to estimate the derivatives in equation (1) is to
use the Maximum Likelihood Estimation (MLE) method. We
assume that at least two cross-sectional surveys were conducted
between t1 and t2 among individuals with ages between a0 and
amax. To estimate the derivatives at a,tð Þ in a0,amaxð Þ| t1,t2ð Þ, we
choose an appropriate rw0 (inclusion window) and for any
observed individual i aged a(i) in a{r,azrð Þ at time t(i), we
approximate his/her probability of being infected at that time by
keeping the terms of the Taylor expansion which are linear in age
and time:
p(a ið Þ,t(i))~a a,tð Þzb a,tð Þ a ið Þ{a
 
zc a,tð Þ t ið Þ{t
  ð2Þ
In the idealised scenario of two cross-sectional surveys
instantaneously executed at time t1 and time t2, the time when
the individual i was surveyed, t(i), is either t1 or t2, and the
individuals are assumed to be independent. The MLE method can
thus be applied to the individual serostatus data to yield maximum
likelihood estimates of a a,tð Þ, b a,tð Þ and c a,tð Þ, which, as shown in
Text S1 (Appendix B), are the estimates of p(a,t),
L
La
p(a,t), and
L
Lt
p(a,t), respectively. Inserting these estimates in equation (1)
together with the excess mortality rate, D(a,t), gives an estimate of
the incidence rate at a,tð Þ. Note that
N this approach is in principle extensible in response to
availability of data, so that higher order terms in the Taylor
expansion may be kept, reducing bias at the cost of increased
variance
N there is no binning of data, and no assumptions about
prevalence being piecewise constant or having any other
special properties.
N One repeats the whole process for every value of a and t at
which an estimate is to be made, and the inclusion window r
can in principle be chosen for each value of (a, t)
N There is no need for sampling to be population representative
in age structure, as there is no averaging being done, which
would require a weighting scheme.
Case of a Birth Cohort
The general ideas of the previous section can be applied to the
estimation of incidence rate in a birth cohort. If we consider
individuals of the same age at time t1 followed up until t2, and then
assume that the prevalence changes linearly with time, we obtain
an explicit expression for our estimator of the incidence rate at any
time t in t1,t2ð Þ (see Text S1, Appendix C). In the case where
t~
t1zt2
2
, we obtain the t1,t2ð Þ-estimator given by:
l^~
2
t2{t1
p^2{p^1
1{p^2{p^1
z
1
2
p^2zp^1ð ÞD ð3Þ
where p^k is the maximum likelihood estimation of the prevalence
at time tk(k~1,2), and D~D tð Þ is the excess mortality rate. We
show in Text S1 (Appendix B) that equation (3) converges to the
true incidence rate when the time gap between the two surveys
tends to zero, in which case the variance diverges in practice.
There, for the special case of a birth cohort, we give the equation
satisfied by the maximum likelihood estimator of the incidence
rate which, in general, cannot be solved analytically.
HIV Incidence Inference
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Comparison to Method of Brunet and Struchiner
Assuming that the excess mortality rate is always positive,
Brunet and Struchiner [24] showed that the incidence rate at age a
can be approximated in the interval t1,t2ð Þ by using the integral
form of equation (1). Their formula expresses the incidence rate as
a function of the integral of the excess mortality rates (which is
assumed to be known) and the prevalence at time t1 and t2. They
suggested a weighted smoothing procedure performed by the
lowess program to create a smooth surface from the observed
prevalence, and to use this smoothed prevalence in their formula
[24]. Brunet and Struchiner’s method differs fundamentally from
the approach suggested in this article in that it uses the integral
form of equation (1) to estimate a locally averaged incidence,
whereas the approach suggested here focuses on the instantaneous
incidence. The estimated incidence given by their approach
converges to the true incidence rate l a,t2ð Þ as t1 tends to t2, and
thus can in principle provide a good approximation of the
incidence rate when the prevalence is observed, with high
accuracy, very frequently. However, when estimating prevalence
shortly after a previous estimate, there may be insufficient
precision to resolve the small changes. On the other hand, when
the time gap is large, it is less likely that the incidence rate is
constant as the method assumes.
Comparison to Method of Hallett et al
Hallett et al. [19] have developed a method based on
simplifying assumptions about population renewal under the
pressure of incidence and mortality (closely related approximations
to exposure times), the assumption of piecewise constant incidence
in age and time bins, and a scheme for ‘pasting together’ exposures in
the time between two age-binned prevalence distributions. This
yields an age binned incidence estimate that is applicable to the
time between the two cross-sectional prevalence surveys. Further
details to facilitate comparison and evaluation can be found in
Text S2 (Section III), where we also calculate asymptotic variances
of some closely related estimators for birth cohorts, which are
compared to the asymptotic variance of the proposed MLE based
incidence estimator, through simulations.
Comparison to Method of Brookmeyer and Konikoff
Brookmeyer and Konikoff [29] recently proposed aggregating
the excess mortality rate of the infected population over the
time between two prevalence surveys conducted at t1 and t2.
This involved the creation of an alternative parameter: the
relative survival rate (R), defined as the ratio of 1) the
probability that a person who is HIV infected and alive at
time t1 survives to t2, to 2) the corresponding probability in the
entire population. An estimator was derived by assuming that:
a) the time interval between the two surveys, and/or the
incidence, is small; b) the probability that an initially uninfected
individual who gets infected during the interval between the
surveys, then survives up to the time of the second survey, is the
same as the ‘probability that a person who is uninfected at time t1
survives to calendar time t2’; and c) the survival probability of an
initially uninfected individual is approximately equal to the
weighted average of the survival probabilities of an initially
uninfected and an initially infected individual. We calculated the
exact expressions of the survival probabilities and R by using
the SI model (see Section III-1 in Text S2). In the limit that t2
immediately follows t1, their estimator shall reduce to that of
the present work, but as the time between surveys grows, the
simplifying assumptions noted above introduce differences.
Simulations
We simulated an epidemic with four phases; the age specific
incidence was constant in time (measured in years) in the first
phase (from 0 to 12), increasing in the second (12 to 18), constant
in the third (18 to 24) and decreasing in the last phase (24 to 30).
Two cross-sectional surveys were simulated in each phase: at times
(5, 9), (13, 17), (19, 23) and (26, 30). We used the generated age
and time specific prevalence to simulate the infection status of
individuals in these surveys (see Text S2, Section II, for further
details). Figure 1 illustrates the true age specific prevalence and
incidence rate in our simulated population at times where the
surveys were conducted and at times where the incidence rate is
estimated. The excess mortality rate was specified as a function of
time and age. Data from each survey consisted of age and HIV
status of 4000 individuals: 200 for each age from 15 to 30 years
and 100 for each age from 31 to 49 years. Finally, for each
simulation, we estimated a a,tð Þ, b a,tð Þ and c a,tð Þ by applying
MLE to the simulated data to estimate the simulated incidence at
time t=7, 15, 21 and 28. The accuracy and precision of the
estimated incidence were investigated by comparing the results of
1000 simulated data sets per scenario, to the input values. The
method of Brunet and Struchiner [24] and the method of Hallett
et al. [19] were also applied to the simulated data.
In the particular case of a population with a common birth date,
we used the closed form of the prevalence (see equation (C2) in
Text S1 Appendix C) to simulate the prevalence of an infection
with differential mortality in a population at time t~t2 given three
parameters: a) the prevalence at the beginning of the observation
period (t~t1); b) the (constant) incidence rate between the two
surveys; and c) a constant excess mortality rate. We used the
simulated prevalence and the excess mortality rates to estimate the
incidence rate using the t1,t2ð Þ-estimator, the estimator proposed
by Hallett et al. for birth cohorts (H-estimator) and the estimator
proposed by Brookmeyer and Konikoff (B-estimator). This allowed
us to measure the bias of these estimators. In the limit of large
sample sizes we also compare the standard deviations of these
estimators to the standard deviation of the optimal estimator (the
numerical solution of equation (C2)).
Sensitivity analysis was performed to assess the effect of the
magnitude of incidence rate and the duration between the two
surveys on estimates of the incidence rate. Scenarios with non-
constant incidence rate were also constructed to investigate the
effect of the assumption of constant incidence rate on the estimate
of incidence rate. In the latter case, the prevalence was simulated
under the hypothesis of varying incidence.
Simulations were run using the R programming language [31].
Software in the form of R code, together with a sample input data
set and complete documentation, is freely available at http://www.
incidence-estimation.com/page/r-code-set-for-manuscript-201203.
Results
Figures 2, 3 and 4 display the simulated and estimated incidence
rates as a function of age for the method developed in this paper,
the method of Brunet and Struchiner and the method of Hallet
et al. The median of 1000 point estimates is represented by the
cross symbol and the error bars represent the central 95 percentile
range.
To facilitate direct comparison of the performance of the three
methods in figures 2–4, we propose an ad-hoc metric of ‘success’ in
recovering, through estimation, the incidence rate which was used
in the simulation. We define a successful estimate, for the use of
two cross sectional prevalence surveys, as one in which the central
95 percentile range of point estimates, based on 1000 randomly
HIV Incidence Inference
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generated data sets, includes the mean of the input incidence rates
used in the interval between surveys. Then, focusing on the
incidence rate in ages up to 30 years, we can see that the ‘success
rate’, as just defined, for the three methods, across all age and time
points reported in figures 2–4, are: 93% (56/60) for the new
method of this paper, 53% (32/60) for the method of Brunet and
Struchiner, and 33% (4/12) for the method of Hallet et al.
Figure 5a shows the true incidence rate for a wide range of
scenarios where the initial prevalence is 10%. In these scenarios,
where both the excess mortality rate and the final prevalence are
less than 30%, the incidence rate cannot exceed 10% per annum if
the time gap is equal to 5 years. Figure 5b indicates that the
absolute error of the t1,t2ð Þ-estimator lays in the range 20.002 to
0.005, for the scenarios represented in Figure 5a.
Additionally we provide a wider view of the ranges of possible
relative errors in Figure 6 when the incidence rate or the time gap
between the measures of prevalence is fixed. Figures 6a and 6b
show that the t1,t2ð Þ-estimator is relatively small when the excess
mortality is less than 40%. The error is zero at ‘endemic equilibrium’,
i.e. when the incidence rate equals excess mortality rate multiplied
by the initial prevalence. In the same way, Figures 6c and 6d show
that the error is positive and increases for large values of the initial
prevalence and excess mortality rates.
Many scenarios were investigated to compare performances of
the t1,t2ð Þ-estimator, the H-estimator and the B-estimator in the
Figure 1. The simulated incidence and prevalence. Simulated age-specific incidence and prevalence at times were the surveys were simulated
and at midpoint of intervals of interest.
doi:10.1371/journal.pone.0044377.g001
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case of a pure birth cohort. Table 1 contains what we hope is an
informative selection of 13 of these scenarios. Note the variability
in the parameter values used to generate these scenarios which are
provided in the first six rows. The 7th, 8th and 9th rows show the
values of the three estimates under these conditions. The ratios of
the standard deviation of each of the estimators to the standard
deviation of the optimal estimator (the numerical solution of
equation (C2)) are available in the last three rows. It appears that:
a) the H-estimator tends to underestimate the incidence rate, the
magnitude of the error being dependent on the excess mortality
rate and the initial prevalence; b) reducing the interval between
prevalence surveys reduces the bias (scenarios # 8, 10 and 11); c)
reducing the excess mortality rate reduces the bias of all the
studied estimators (scenario #2); d) the bias of the B-estimator is
comparable to the bias of the H-estimator, e) the relative error of
the t1,t2ð Þ-estimator does not exceed 3%; f) the asymptotic
standard error of the t1,t2ð Þ-estimator was comparable to the
standard error of the optimal estimator of the incidence rate; and
g) the asymptotic standard error of the B-estimator was lower than
the asymptotic standard error of the t1,t2ð Þ-estimator while the
asymptotic standard error of the H-estimator was higher than
the standard error of the optimal estimator except when the
background mortality rate was very small.
Non-constant incidence rate appears to have only a modest
impact on our method. In the case of an increasing incidence
rate with a constant slope l= t2{t1ð Þ (with l and t2{t1 taken
from the scenarios described in Table 1), and the incidence rate
equals to l at time t2zt1ð Þ=2 , we observed that the t1,t2ð Þ-
Figure 2. Incidence rates using the MLE approach. The number of replications was 1000 for all the analyses and confidence limits (95% CL)
were obtained by the percentile method. The inclusion window rð Þ was chosen as follow. a) Period 1, 2 and 3: for times in the interval 4,18ð Þ, r~1 for
each age from 15 to 16, r~2 for each age from 17 to 22, r~3 for each age from 23 to 35, and r~4 for ages greater than 35. b) Period 4: for times in
the interval 25,31ð Þ, r~1 for each age from 15 to 16, r~2 for each age from 17 to 22, r~4 for each age from 23 to 35, and r~8 for ages greater than
35.
doi:10.1371/journal.pone.0044377.g002
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estimator overestimated the incidence rate with a relative error
less than 4%. Similarly, under the assumption of decreasing
incidence rate with a constant slope of l= t2{t1ð Þ (with l and
t2{t1 taken from the scenarios described in Table 1), and the
incidence rate equal to l at time t2zt1ð Þ=2 , we observed that
the t1,t2ð Þ-estimator underestimated the incidence rate with a
relative error less than 9%.
Additionally, we performed sensitivity analysis for all the
scenarios to see how well the t1,t2ð Þ- and the B- and H- estimators
performed with an imperfect knowledge of the excess mortality
rate (D). When we increased D by 20%, the t1,t2ð Þ-estimator
overestimated the incidence rate by no more than 9% while it
underestimated the incidence rate by no more than 14% when we
decreased D by 20%. In similar conditions, the H-estimator and
the B-estimator underestimated the incidence rate with an error
varying from 3% to 40%.
Discussion
The method of estimating incidence rates which we have
developed is fundamentally comprised of
N an exact relationship (equation (1)) which formally expresses
the force of infection (incidence rate) in terms of the excess
mortality rate of the infected state and the current value and
rate of change (with respect to age and time) of prevalence; and
N direct estimation of each component of the right hand side of
this relationship.
We specifically explored the use of Maximum Likelihood
Estimation and a Taylor Series expansion for estimating the
required prevalence and its derivatives from individual-level
serostatus data, and left open the question of how best to estimate
the excess mortality rate in the infected state. This is essentially an
Figure 3. Incidence rates using the approach of Brunet and Struchiner [24]. The number of replications was 1000 for all the analyses and
confidence limits (95% CL) were obtained by the percentile method.
doi:10.1371/journal.pone.0044377.g003
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instantaneous and individual level formulation of what was cast in
aggregated form in previous work, most notably that of Brunet and
Struchiner [24], which assumed constant incidence between
surveys, and the later work, using additional assumptions, of
Hallett et al. [19] and Brookmeyer and Konikoff [29]. Perhaps the
fundamental difference in approach is that previous efforts to
estimate incidence within this broad paradigm have been based on
the idea of a formal solution to a complex dynamical problem, in
which a later population state is expressed explicitly in terms of an
earlier population state and dynamical rules presumed to have
been in effect over the intervening time. This cannot be done in
closed form, and indeed is ill posed as dynamical rules can vary in
the time interval, hence the use of simplifying assumptions. The
present work avoids these difficulties by extracting the estimator
directly from the dynamical rules/equations, rather than from a
‘solution’.
A consequence of using formal estimation techniques directly on
unaggregated serostatus data is that questions of averaging, and
hence of weighting, which complicated bin-based analyses, simply
do not arise, and neither does the need for age-representative
sampling of study populations. In Text S2 we show how this
approach, under additional assumptions, yields key formulas
previously used to estimate HIV incidence [18,23] or more
generally, to estimate incidence of infections with differential
mortality [20,25].
Also, estimating incidence rate for a particular age, at a
particular point in time, does not require knowledge of the excess
mortality rate in an entire interval as in Brunet et al. [24] or the
additional assumptions in Hallett et al. [19] and Brookmeyer or
Konikoff, such as that incidence rate was small, remained stable in
the interval between the surveys and was constant in age bins, or
that individuals who become infected between the two surveys
Figure 4. Incidence rates estimated in age bins using the approach of Hallett et al. [19]. The number of replications was 1000 for all the
analyses and confidence limits (95% CL) were obtained by the percentile method.
doi:10.1371/journal.pone.0044377.g004
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survive up to the last survey. Our mathematical analysis (see
Section III-1 of Text S2) and numerical simulations showed that
these other estimators appear to have significant bias, even with
perfect knowledge of prevalence and mortality, sometimes with an
inappropriately small formal variance.
Incidence rates can thus, in principle, be estimated for any
age, at any time, as long as there is sufficient serostatus and
mortality data within a suitable inclusion zone around this point
in the age/time domain. The inclusion window can be varied to
provide an intuitively straightforward trade-off between variance
(less variance with more data) and bias (more bias as data further
from the point of interest is interpreted with the low order terms
in the Taylor series). While the nature of the trade off is clear
enough, and the example calculations suggest the use of
serostatus data within 2–5 years of the age of interest (see Figure
S4 in Text S2), an experimenter in possession of a single data set (as
opposed to a simulator with access to arbitrarily many, in addition to
the correct answer) cannot directly use this idea to self-diagnose
the optimal value of this inclusion criterion. Simulating a num-
ber of different scenarios (all of which produce data sufficiently
like the real data), will support the choice of robust inclusion
criteria.
In this study, we reported 95 percentile ranges of point estimates
obtained from a large number of generated data sets. This only
makes sense when using simulated data. In a real world context,
where serological statuses are observed only once, the bootstrap
method described in Text S2 (Section V) can be used to calculate
confidence intervals when the sample size is large. When the
asymptotic normality is violated, however, the bootstrap method
consisting of sampling the individuals with replacement can still be
used.
Useful incidence estimates will require sufficiently representative,
and numerous, individual HIV serostatus data, and, more
problematically, sufficiently accurate and precise excess mortality
rate estimates; the challenge being that mortality among HIV
infected individuals is related to the incidence in the past, virus sub-
type, the availability of Antiretroviral treatment (ART) in the
population, etc. Equation (1) suggests that an error in themeasure of
the excess mortality rate is expected to induce bias in the incidence
rate estimate which is of magnitude approximately equal to the bias
on the excessmortality ratemultiplied by the prevalence. Hence, given
a reasonable external mortality rate estimate, the bias should be
smallest amongst younger people, where the excess mortality rate is
low. The problemof error induced by inaccuracy and imprecision of
excess mortality rates is inherent to all methodology aiming at
Figure 5. Incidence and absolute error of the t1,t2ð Þ-estimator. Contour lines for the true incidence (in percentage) and contour lines for the
absolute error (in percentage as well) for the MLE approach in a cohort study in the case where the initial prevalence, p1 is 0.1 and the time between
the two surveys is 5 years.
doi:10.1371/journal.pone.0044377.g005
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estimating HIV incidence from prevalence data, and suggests that
this be the focus of substantial additional research, both for the
usually primary aim of elucidating the impact of HIV, and for the
purpose of stabilising incidence estimates.
Some methodologies for estimating reliable excess mortality
rates due to HIV/AIDS have been suggested [32]. Indeed, the
estimation of differential mortality is easier for countries where
causes of deaths are registered. For developing countries, where
deaths records are difficult to access, the verbal autopsy can be
used [32]. That method is increasingly used and was shown able to
provide reliable mortality rates and detect HIV-related deaths
[32–34]. What is less clear, and warrants further investigation, is
how this data is best analysed to yield differential mortality rates
stratified by age and (calendar) time, as opposed to stratified by age
and time since infection. Furthermore, the increasing availability of
ART, will impact the excess mortality associated with HIV
infection for years to come.
It is worth noting that our approach can in principle be applied
in the more general setting where the population is subject to in-
and/or out-migration. In this case, the excess mortality is replaced by
the difference, between infected and uninfected populations, in the
‘net attrition rates’, which would then need be known with sufficient
accuracy and precision, much as the base case requires knowledge
of differential mortality (for further details on accounting for
migration/immigration, and the impact of ART, see Section IV of
Text S2). Of course, the method is also not restricted solely to the
area of HIV incidence estimation and can be used to estimate the
incidence rate of any non-remissible infection with differential
mortality.
The accurate estimation of HIV incidence will remain a very
important issue in public health for many years into the
foreseeable future. Given that following cohorts of individuals
over time is time consuming, expensive and administratively
intensive, and furthermore at risk of yielding biased estimates, a
method which allows for the accurate estimation of incidence from
Figure 6. Relative error of the t1,t2ð Þ-estimator as a function of the initial prevalence. Contour lines for the relative error (in percentage) on
the incidence when using the MLE approach in a birth cohort in the case where the duration between the two surveys or the initial prevalence, p1
varies.
doi:10.1371/journal.pone.0044377.g006
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cross sectional surveys is of great value. The method proposed in
this paper makes no assumptions regarding the epidemiological
scenario and in the case of an infinite amount of data, is exact. The
only factors which limit the performance of the method are the
quality/quantity of the HIV serostatus data, and excess mortality
estimates, both of which have been increasing significantly. The
three point plan outlined at the beginning of this section provides a
break with the artefacts of previous approaches to the use of
prevalence and mortality data for estimating HIV incidence, and a
systematic framework within which limitations can be better
diagnosed as data is analysed.
Supporting Information
Text S1 contains a simple derivation of Equation (1) the
maximum likelihood equations. Derivation of key formulas and
technical details of the simulations are given in the Text S2 which
also contains an equivalent model and derivation of the equations
of some published models to estimate HIV incidence rates from
prevalence data. Text S2 also contains description and numerical
results of ad hoc methods using aggregated prevalence data to
estimate incidence rate as a function of age and ends with a
description of the ways to estimate confidence limits of the curve of
incidence.
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Table 1. Performances of the estimators of the incidence rates of an infection with a differential mortality in the case of a birth
cohort with constant incidence as well as constant background and excess mortalities.
Scenarios 1 2 3 4 5 6 7 8 9 10 11 12 13
Data
m 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02
m 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2
t22t1 5 5 5 5 5 5 5 3 5 3 3 5 5
p1 0.1 0.1 0.05 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1
p2 0.24 0.30 0.21 0.29 0.19 0.14 0.24 0.19 0.18 0.12 0.19 0.24 0.19
l 0.05 0.05 0.05 0.05 0.05 0.02 0.05 0.05 0.05 0.02 0.05 0.05 0.05
Incidence estimates
l^ 0.049 0.050 0.049 0.050 0.049 0.020 0.049 0.050 0.049 0.020 0.050 0.049 0.049
lH 0.039 0.048 0.039 0.040 0.032 0.016 0.039 0.043 0.039 0.017 0.043 0.039 0.031
lB 0.038 0.044 0.037 0.039 0.032 0.016 0.038 0.042 0.036 0.017 0.042 0.038 0.032
Ratio* of the se
se l^
 
=se l^0
 
0.97 0.98 0.97 0.98 0.95 0.98 0.97 0.99 0.97 0.99 0.99 0.97 0.94
se lH
 
=se l^0
 
1.16 0.93 1.13 1.20 1.35 4.50 1.16 1.85 1.09 7.83 2.66 2.64 1.80
se lB
 
=se l^0
 
0.69 0.78 0.67 0.71 0.60 0.76 0.69 0.78 0.66 0.84 0.78 0.69 0.60
We used the exact prevalence for the simulations.
m: background mortality rate;
m: excess mortality rate;
t2{t1 : time between the two surveys;
p1 : initial prevalence, at t~t1 ;
p2 : initial prevalence, at t~t2 ;
l: simulated incidence;
l^: incidence rate estimated using the t1,t2ð Þ-estimator;
lH : incidence rate estimated using the H-estimator which was proposed by Hallett et al. [19] for birth cohort;
lB : incidence rate estimated using the B-estimator which was proposed by Brookmeyer and Konikoff. [29];
l^0 : incidence rate estimated using the optimal estimator obtained by solving the maximum likelihood equations (see equation (C2) in Text S1, Appendix C).
se: Standard error; here, the standard deviations were estimated using the delta method; the ratios were calculated under the assumption that the numbers of
individuals in the two surveys are the same.
*: Ratio of the se to the se of the optimal estimator.
doi:10.1371/journal.pone.0044377.t001
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